Darktrace, a Cambridge, UK-based developer of enterprise immune system technology, raised $18m in funding.
Backers in the round, which valued the company at $80m, included Invoke Capital, Talis Capital, Hoxton Ventures and private individuals.
The company intends to use the funds to continue to grow globally mainly expanding into Asia Pacific.
Founded in 2013 and led by CEO Nicole Eagan, Darktrace has developed enterprise immune system technology which leverages advanced machine learning and mathematics developed at the University of Cambridge to protect companies by detecting threats in real time and analyzing the behavior of every device, user and network within an organization.
The company has opened up operations in Asia Pacific and Sanjay Aurora, who has over 25 years’ experience leading enterprise software firms, will oversee the expansion process in the region. He will be joined by John Muser, formerly of IBM Security, heading up Australia and New Zealand, and Stanley Hsu, formerly of McAfee Intel, leading emerging markets in South East Asia.
Customers include BT, Virgin Trains and Drax, among other large corporations in energy and utilities, financial services, telecommunications, healthcare, manufacturing, retail and transportation sectors.
Darktrace has offices in London, Milan, New York, Paris, San Francisco, Singapore and Washington D.C.